Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1568-1573.
Prepublished online as a Blood First Edition Paper on October 5, 2006; DOI 10.1182/blood-2006-06-031856.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
blood-2006-06-031856v1
109/4/1568    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, P. C.
Right arrow Articles by Ochoa, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, P. C.
Right arrow Articles by Ochoa, A. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 26, 2006
Accepted September 26, 2006

L-Arginine availability regulates T lymphocyte cell cycle progression

Paulo C. Rodriguez*, David G. Quiceno, and Augusto C. Ochoa

Tumor Immunology Program, Stanley S. Scott Cancer Center, Louisiana State University, Health Sciences Center, New Orleans, LA, United States
Dept of Pediatrics, Louisiana State University, Health Sciences Center, New Orleans, LA, United States

* Corresponding author; email: prodri1{at}lsuhsc.edu.

L-Arginine (L-Arg) plays a central role in several biological systems including the regulation of T cell function. L-Arg depletion by myeloid suppressor cells producing arginase I is seen in patients with cancer inducing T cell anergy. We studied how L-Arg starvation could regulate T cell cycle progression. Stimulated T cells cultured in the absence of L-Arg are arrested in G0-G1 phase of the cell cycle. This was associated with an inability of T cells to upregulate cyclin D3 and cyclin-dependent kinase 4 (cdk4), but not cdk6, resulting in an impaired downstream signaling with a decreased phosphorylation of Rb protein and a low expression and binding of E2F1. Silencing of cyclin D3 reproduced the cell cycle arrest caused by L-Arg starvation. The regulation of cyclin D3 and cdk4 by L-Arg starvation occurs at transcriptional and post-transcriptional levels. Signaling through GCN2 kinase is triggered during amino acid starvation. Experiments demonstrated that T cells from GCN2 knockout mice did not show a decreased proliferation and were able to upregulate cyclin D3 when cultured in the absence of L-Arg. These results contribute to understand a central mechanism by which cancer and other diseases characterized by high arginase I production may cause T cell dysfunction.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020